CING

SEC source: 0001493152-24-009087 · ownership.xml · derivative · entry 1

Callahan Jennifer L. · CIK 0001883523 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,014

Underlying: Common Stock · 25,014 shares

Expires 2034-03-04

F1 · derivative.exercise_date: The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date.

SEC source: 0001493152-24-004170 · ownership.xml · derivative · entry 1

Werth Peter J. · CIK 0001883257 · Director · 10% owner

Werth Family Investment Associates LLC · CIK 0001885004 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Werth Family Investment Associates LLC

Disclosed balance after: 687,043

Underlying: Common Stock · 687,043 shares

Expires not disclosed

F1 · kind: On January 25, 2024, the Issuer and Cingulate Therapeutics LLC ("CTx"), a wholly-owned subsidiary of the Issuer, entered into a Note Conversion Agreement with Werth Family Investment Associates LLC ("WFIA"), pursuant to which WFIA agreed to convert the remaining principal amount plus all accrued interest thereon, or $3,287,500, under the Amended and Restated Promissory Note, dated May 9, 2023, that CTx issued to WFIA into pre-funded warrants to purchase 687,043 shares of common stock of the Issuer, at a conversion price per pre-funded warrant of $4.785.

F1 · price: On January 25, 2024, the Issuer and Cingulate Therapeutics LLC ("CTx"), a wholly-owned subsidiary of the Issuer, entered into a Note Conversion Agreement with Werth Family Investment Associates LLC ("WFIA"), pursuant to which WFIA agreed to convert the remaining principal amount plus all accrued interest thereon, or $3,287,500, under the Amended and Restated Promissory Note, dated May 9, 2023, that CTx issued to WFIA into pre-funded warrants to purchase 687,043 shares of common stock of the Issuer, at a conversion price per pre-funded warrant of $4.785.

F2 · derivative.expiration_date: The pre-funded warrants have no expiration date and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of common stock of the Issuer.

F3 · ownership.nature: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001493152-24-000146 · ownership.xml · derivative · entry 1

Silva Raul R. · CIK 0001883270 · EVP and CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2033-12-29

F1 · date: The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.

SEC source: 0001493152-23-035082 · ownership.xml · derivative · entry 1

Silva Raul R. · CIK 0001883270 · EVP and CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2033-09-29

F1 · date: The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.

SEC source: 0001493152-23-032961 · ownership.xml · nonDerivative · entry 1

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,508

SEC source: 0001493152-23-032275 · ownership.xml · derivative · entry 1

Werth Peter J. · CIK 0001883257 · Director · 10% owner

Werth Family Investment Associates LLC · CIK 0001885004 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Werth Family Investment Associates LLC

Disclosed balance after: 6,838,235

Underlying: Common Stock · 6,838,235 shares

Expires not disclosed

F1 · kind: On August 9, 2022, Cingulate Therapeutics LLC ("CTx"), a wholly-owned subsidiary of the Issuer, issued a Promissory Note (the "Original Note") to Werth Family Investment Associates LLC ("WFIA") with a principal amount of $5,000,000 (the "Original Principal Amount"), and on May 9, 2023, CTx issued an Amended and Restated Promissory Note (the "A&R Note") increasing the principal amount under the Original Note by $3,000,000 to $8,000,000. On September 8, 2023, the Issuer and CTx entered into a Note Conversion Agreement (the "Note Conversion Agreement") with WFIA, pursuant to which WFIA agreed to convert the Original Principal Amount under the A&R Note plus all accrued interest thereon, or $5,812,500, into pre-funded warrants to purchase 6,838,235 shares of common stock of the Issuer, at a conversion price per pre-funded warrant of $0.85

F1 · price: On August 9, 2022, Cingulate Therapeutics LLC ("CTx"), a wholly-owned subsidiary of the Issuer, issued a Promissory Note (the "Original Note") to Werth Family Investment Associates LLC ("WFIA") with a principal amount of $5,000,000 (the "Original Principal Amount"), and on May 9, 2023, CTx issued an Amended and Restated Promissory Note (the "A&R Note") increasing the principal amount under the Original Note by $3,000,000 to $8,000,000. On September 8, 2023, the Issuer and CTx entered into a Note Conversion Agreement (the "Note Conversion Agreement") with WFIA, pursuant to which WFIA agreed to convert the Original Principal Amount under the A&R Note plus all accrued interest thereon, or $5,812,500, into pre-funded warrants to purchase 6,838,235 shares of common stock of the Issuer, at a conversion price per pre-funded warrant of $0.85

F2 · derivative.expiration_date: The pre-funded warrants have no expiration date and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer.

F3 · ownership.nature: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001493152-23-028563 · ownership.xml · nonDerivative · entry 1

Werth Peter J. · CIK 0001883257 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Werth Family Investment Associates LLC

Disclosed balance after: 2,798,320

F1 · kind: The purchase was made in a private transaction with the Issuer that closed on August 11, 2023.

F2 · ownership.nature: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001493152-23-023353 · ownership.xml · derivative · entry 1

Silva Raul R. · CIK 0001883270 · EVP and CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2033-06-30

F1 · date: The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.

SEC source: 0001493152-23-021770 · ownership.xml · derivative · entry 1

Werth Peter J. · CIK 0001883257 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-06-15

F1 · derivative.exercise_date: The option vests on the one-year anniversary of the date of grant.

SEC source: 0001493152-23-021773 · ownership.xml · derivative · entry 1

GIVENS GREGG WM · CIK 0001189317 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-06-15

F1 · derivative.exercise_date: The option vests on the one-year anniversary of the date of grant.

SEC source: 0001493152-23-021772 · ownership.xml · derivative · entry 1

Gallagher Patrick Joseph · CIK 0001648003 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-06-15

F1 · derivative.exercise_date: The option vests on the one-year anniversary of the date of grant.

SEC source: 0001493152-23-021771 · ownership.xml · derivative · entry 1

Applebaum Scott · CIK 0001618945 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-06-15

F1 · derivative.exercise_date: The option vests on the one-year anniversary of the date of grant.

SEC source: 0001493152-23-021769 · ownership.xml · derivative · entry 1

Medeiros Curtis · CIK 0001801084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-06-15

F1 · derivative.exercise_date: The option vests on the one-year anniversary of the date of grant.

SEC source: 0001493152-23-017842 · ownership.xml · nonDerivative · entry 2

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,508

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0097 to $1.01 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

SEC source: 0001493152-23-017842 · ownership.xml · derivative · entry 3

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,530

Underlying: Common Stock · 1,030 shares

Expires 2026-12-10

F2 · price: The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.1076 to $0.11 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth herein.

SEC source: 0001493152-23-017842 · ownership.xml · nonDerivative · entry 1

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,508

SEC source: 0001493152-23-010687 · ownership.xml · derivative · entry 1

Silva Raul R. · CIK 0001883270 · EVP and CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2033-03-31

F1 · date: The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.

SEC source: 0001493152-23-007046 · ownership.xml · derivative · entry 1

Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2033-02-28

F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.

SEC source: 0001493152-23-007043 · ownership.xml · derivative · entry 1

Gilgallon Craig S. · CIK 0001883241 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2033-02-28

F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.

SEC source: 0001493152-23-007048 · ownership.xml · derivative · entry 1

VAN HORN LOUIS G · CIK 0001224126 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2033-02-28

F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.

SEC source: 0001493152-23-007044 · ownership.xml · derivative · entry 1

Myers Laurie · CIK 0001883920 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2033-02-28

F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.

SEC source: 0001493152-23-007042 · ownership.xml · derivative · entry 1

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-02-28

F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.

SEC source: 0001493152-23-007040 · ownership.xml · derivative · entry 1

Brams Matthew · CIK 0001884361 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-02-28

F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.

SEC source: 0001493152-23-000167 · ownership.xml · derivative · entry 1

Silva Raul R. · CIK 0001883270 · EVP and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,084

Underlying: Common Stock · 16,084 shares

Expires 2032-12-30

F1 · date: The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.

SEC source: 0001493152-22-035892 · ownership.xml · derivative · entry 4

Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,738

Underlying: Common Stock · 200 shares

Expires 2026-12-10

SEC source: 0001493152-22-035892 · ownership.xml · nonDerivative · entry 1

Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,500

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.00 to 1.0199 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth

SEC source: 0001493152-22-035892 · ownership.xml · derivative · entry 3

Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,538

Underlying: Common Stock · 3,642 shares

Expires 2026-12-10

F3 · price: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2506 to $0.262 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth.

SEC source: 0001493152-22-035633 · ownership.xml · nonDerivative · entry 2

Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,500

SEC source: 0001493152-22-035631 · ownership.xml · nonDerivative · entry 1

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,508

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.94 to $1.00 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

SEC source: 0001493152-22-035633 · ownership.xml · derivative · entry 4

Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,896

Underlying: Common Stock · 396 shares

Expires 2026-12-10

F2 · price: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2458 to $0.262 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth.

SEC source: 0001493152-22-035633 · ownership.xml · nonDerivative · entry 1

Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,233

SEC source: 0001493152-22-035632 · ownership.xml · nonDerivative · entry 1

Werth Peter J. · CIK 0001883257 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Werth Family Investment Associates LLC

Disclosed balance after: 975,165

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9781 to $1.00 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

F2 · ownership.nature: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001493152-22-034042 · ownership.xml · nonDerivative · entry 2

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,960

SEC source: 0001493152-22-034042 · ownership.xml · nonDerivative · entry 1

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,430

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9798 to $0.98 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

SEC source: 0001493152-22-033848 · ownership.xml · nonDerivative · entry 1

Gilgallon Craig S. · CIK 0001883241 · EVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,550

SEC source: 0001493152-22-034191 · ownership.xml · nonDerivative · entry 1

Myers Laurie · CIK 0001883920 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,263

SEC source: 0001493152-22-033748 · ownership.xml · nonDerivative · entry 1

GIVENS GREGG WM · CIK 0001189317 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,318

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.92 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

SEC source: 0001493152-22-027618 · ownership.xml · derivative · entry 1

Silva Raul R. · CIK 0001883270 · EVP and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,032

Underlying: Common Stock · 15,032 shares

Expires 2032-09-30

F1 · date: The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.

SEC source: 0001493152-22-025404 · ownership.xml · nonDerivative · entry 1

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,943

SEC source: 0001493152-22-025401 · ownership.xml · nonDerivative · entry 1

Werth Peter J. · CIK 0001883257 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Werth Family Investment Associates LLC

Disclosed balance after: 946,231

F1 · ownership.nature: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001493152-22-025156 · ownership.xml · nonDerivative · entry 1

Myers Laurie · CIK 0001883920 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,352

SEC source: 0001493152-22-022131 · ownership.xml · derivative · entry 1

Applebaum Scott · CIK 0001618945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2032-08-09

F1 · derivative.exercise_date: The option vests on the one-year anniversary of the date of grant.

SEC source: 0001493152-22-018403 · ownership.xml · derivative · entry 1

Silva Raul R. · CIK 0001883270 · EVP and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,017

Underlying: Common Stock · 11,017 shares

Expires 2032-06-30

F1 · date: The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.

SEC source: 0001493152-22-015888 · ownership.xml · nonDerivative · entry 1

Myers Laurie · CIK 0001883920 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,716

SEC source: 0001493152-22-025156 · ownership.xml · nonDerivative · entry 2

Myers Laurie · CIK 0001883920 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,152

SEC source: 0001493152-22-014519 · ownership.xml · nonDerivative · entry 1

Myers Laurie · CIK 0001883920 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,516

SEC source: 0001493152-22-026717 · ownership.xml · nonDerivative · entry 1

Medeiros Curtis · CIK 0001801084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: These shares were sold by the Reporting Person's broker without instruction from, or knowledge by, the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.35 per share. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

SEC source: 0001493152-22-007285 · ownership.xml · nonDerivative · entry 1

Werth Peter J. · CIK 0001883257 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Werth Family Investment Associates LLC

Disclosed balance after: 871,731

F1 · ownership.nature: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001493152-22-007286 · ownership.xml · nonDerivative · entry 1

Myers Laurie · CIK 0001883920 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,316

SEC source: 0001493152-22-007284 · ownership.xml · derivative · entry 2

Callahan Jennifer L. · CIK 0001883523 · Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,500

Underlying: Common Stock · 16,879 shares

Expires 2026-12-10

F1 · price: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2151 to $0.22 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth herein.